Leni van Doorn
Leni van Doorn publishes mostly in Oncology, Pulmonary and Respiratory Medicine and Surgery, on topics such as Gastric Cancer Management and Outcomes, Cancer Treatment and Pharmacology and Hepatocellular Carcinoma Treatment and Prognosis.
- World rank
- #1,362,441 of 7,710,434 ranked researchers
- Rank in Netherlands
- #30,915 of 107,149
- Works
- 111
- Citations
- 1.7k
- Citations per work
- 15.8
What does Leni van Doorn research?
Leni van Doorn's work is mostly in Medicine (57%), Biochemistry, Genetics and Molecular Biology (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6356.7%
- Medicine6356.7%
- Everything else3330.0%
- Life Sciences1513.3%
- 1Oncology23% of their works
- 2Pulmonary and Respiratory Medicine16% of their works
- 3Surgery11% of their works
- 4Molecular Biology9% of their works
- 5Hepatology6% of their works
- 6Cancer Research4% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Cancer Treatment and Pharmacology
- Hepatocellular Carcinoma Treatment and Prognosis
- Lung Cancer Treatments and Mutations
- Esophageal Cancer Research and Treatment
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Angiogenesis and VEGF in Cancer
Which keywords describe Leni van Doorn's research?
The keywords of their largest research topics: Chemotherapy, Clinical Practice Guidelines, Endoscopic Resection, Neoadjuvant Therapy, Gastric Cancer, Molecular Characterization, Chemotherapy-Induced Peripheral Neuropathy and Taxanes.
- endothelial progenitor cells
- Surgical Complications
- KRAS Mutations
- Targeted Therapy
- Liver Cancer
- Esophageal Carcinoma
- Taxanes
- Molecular Characterization
- Neoadjuvant Therapy
- Clinical Practice Guidelines
- Chemotherapy
- Endoscopic Resection
- Gastric Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- EGFR Mutations
- Hepatocellular Carcinoma
- Preoperative Chemoradiotherapy
- Cetuximab
- Pancreatic Cancer
- VEGF
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Chemotherapy343 topics
- Clinical Practice Guidelines272 topics
- Endoscopic Resection272 topics
- Neoadjuvant Therapy202 topics
- Gastric Cancer151 topic
- Molecular Characterization151 topic
- Chemotherapy-Induced Peripheral Neuropathy141 topic
- Taxanes141 topic
- EGFR Mutations121 topic
- Esophageal Carcinoma121 topic
- Hepatocellular Carcinoma121 topic
- Liver Cancer121 topic
- Preoperative Chemoradiotherapy121 topic
- Targeted Therapy121 topic
- Cetuximab111 topic
- KRAS Mutations111 topic
- Pancreatic Cancer81 topic
- Surgical Complications81 topic
- VEGF71 topic
- endothelial progenitor cells71 topic
Where does Leni van Doorn work?
Leni van Doorn's main affiliation in the publication record is Erasmus MC Cancer Institute, Netherlands.
How many publications and citations does Leni van Doorn have?
OpenAlex counts 111 works and 1,749 citations for Leni van Doorn, an h-index of 23, ranking #1,362,441 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Leni van Doorn. Posts are plain text and can be reported.